T2DM (TYPE 2 DIABETES MELLITUS)

This study tests whether adding ganagliflozin tablets to standard treatment can slow the worsening of kidney disease in people with type 2 diabetes and chronic kidney disease. About 1,244 adults will receive either the drug or a placebo for 120 weeks. The main goal is to see if t…

This study looks at whether adding a third drug (dulaglutide) to an already effective two-drug combination can provide extra kidney protection for Chinese adults with type 2 diabetes and mild-to-moderate chronic kidney disease. About 468 participants who have been on the two-drug…

This study tests whether starting treatment with two experimental drugs together (DWP16001 and DWC202518) works better than either drug alone for people with type 2 diabetes. About 510 adults will take the combo or a single drug for 24 weeks, and researchers will measure changes …

This study tests a procedure called ReCET for people with type 2 diabetes and fatty liver disease who haven't had good blood sugar control with pills. The procedure uses electrical pulses to treat the lining of the small intestine. The goal is to see if it can improve blood sugar…

This study tests a new once-daily tablet that combines three diabetes drugs (henagliflozin, retagliptin, and metformin) in Chinese adults with type 2 diabetes. About 300 participants will take the pill for 24 weeks to see how well it lowers blood sugar and check for side effects.…

This study looks at adding a drug called Chiglitazar to standard SGLT-2 inhibitor treatment for adults with type 2 diabetes whose blood sugar is not well controlled. Researchers will track changes in blood sugar, heart, kidney, and liver health over time. About 3550 participants …

This study tests whether a new tablet that combines two diabetes drugs (Chiglitazar and Metformin) works the same in the body as taking the two drugs separately. It involves 24 healthy adults who will take both versions under fed conditions. The goal is to see if the combination …

This study tests whether a new single pill that combines two diabetes drugs (chiglitazar and metformin) works the same as taking them separately. It involves 64 healthy adults who will take both versions and have their blood levels measured. The goal is to see if the combo pill i…

This early-stage study looks at how a high-fat meal changes the way a new diabetes pill (Chiglitazar/Metformin) is absorbed and processed in the body. It also checks how the drug builds up over multiple doses. The study involves 28 healthy Chinese adults aged 18-45 and does not a…